Fidelity Investments’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $32.4K | Sell |
505
-95
| -16% | -$6.09K | ﹤0.01% | 4092 |
|
|
2025
Q1 | $38.1K | Sell |
600
-67
| -10% | -$4.25K | ﹤0.01% | 3975 |
|
|
2024
Q4 | $44.3K | Sell |
667
-125
| -16% | -$8.31K | ﹤0.01% | 3905 |
|
|
2024
Q3 | $55.3K | Sell |
792
-170
| -18% | -$11.9K | ﹤0.01% | 3732 |
|
|
2024
Q2 | $62.4K | Buy |
962
+724
| +304% | +$46.9K | ﹤0.01% | 3497 |
|
|
2024
Q1 | $15.4K | Sell |
238
-422
| -64% | -$27.3K | ﹤0.01% | 4116 |
|
|
2023
Q4 | $43.5K | Buy |
660
+331
| +101% | +$21.8K | ﹤0.01% | 3574 |
|
|
2023
Q3 | $18.8K | Sell |
329
-366
| -53% | -$20.9K | ﹤0.01% | 3841 |
|
|
2023
Q2 | $42.6K | Buy |
695
+450
| +184% | +$27.6K | ﹤0.01% | 3510 |
|
|
2023
Q1 | $15.4K | Hold |
245
| – | – | ﹤0.01% | 3957 |
|
|
2022
Q4 | $15.6K | Buy |
245
+30
| +14% | +$1.91K | ﹤0.01% | 3865 |
|
|
2022
Q3 | $13K | Hold |
215
| – | – | ﹤0.01% | 3992 |
|
|
2022
Q2 | $12K | Sell |
215
-209
| -49% | -$11.7K | ﹤0.01% | 4063 |
|
|
2022
Q1 | $26K | Sell |
424
-41
| -9% | -$2.51K | ﹤0.01% | 3919 |
|
|
2021
Q4 | $33K | Buy |
465
+231
| +99% | +$16.4K | ﹤0.01% | 3336 |
|
|
2021
Q3 | $18K | Buy |
234
+144
| +160% | +$11.1K | ﹤0.01% | 3467 |
|
|
2021
Q2 | $7K | Hold |
90
| – | – | ﹤0.01% | 3642 |
|
|
2021
Q1 | $7K | Buy |
90
+88
| +4,400% | +$6.84K | ﹤0.01% | 3478 |
|
|
2020
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 4172 |
|
|
2020
Q1 | – | Sell |
-101
| Closed | -$6K | – | 4078 |
|
|
2019
Q4 | $6K | Hold |
101
| – | – | ﹤0.01% | 3368 |
|
|
2019
Q3 | $5K | Buy |
101
+100
| +10,000% | +$4.95K | ﹤0.01% | 3402 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 4056 |
|